PMID: 6105246Jul 12, 1980Paper

Reappraisal of plateau phase in myeloma

Lancet
B G DurieS Salmon

Abstract

The frequency with which the plateau of stable phase occurs after remission-induction chemotherapy, and the kinetic features of this phase, were evaluated in 127 carefully staged patients with multiple myeloma. 56 patients (44%) entered a stable plateau state, this pattern being most common in patients with stages IA, IIA, and IIIA of the disease, and least likely in those with stages IIB or IIIB, especially those with Bence Jones protein only or Bence Jones protein plus a serum M-component. Tritiated thymidine labelling index (LI) of bone-marrow myeloma cells, polyamine measurements, and in-vitro myeloma stem-cell culture findings all indicated that the plateau phase is a cytokinetically quiescent state, compared with the more active induction and relapse phases. The major implications of these findings include the avoidance of aggressive "cycle active" treatment and discontinuation of maintenance treatment in plateau-phase patients.

References

Oct 1, 1977·The Journal of Clinical Investigation·A Hamburger, S E Salmon
Jul 29, 1977·Science·A W Hamburger, S E Salmon
Dec 1, 1977·Cancer·R AlexanianJ Weick
Oct 1, 1978·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A RiccardiS Perugini
Dec 12, 1975·Science·B G Durie, S E Salmon
Sep 1, 1966·Cancer·H CoonsA M Nahum
Sep 1, 1974·Cancer·B DrewinkoR Alexanian
Jun 1, 1970·The Journal of Clinical Investigation·S E Salmon, B A Smith
Jul 1, 1972·The Journal of Clinical Investigation·P W Sullivan, S E Salmon

❮ Previous
Next ❯

Citations

Mar 1, 1995·Medical Oncology·V M Lauta
Jan 1, 1997·International Journal of Clinical & Laboratory Research·M A FrassanitoF Dammacco
Aug 1, 1985·Cancer Genetics and Cytogenetics·M R MacKenzie, J P Lewis
Oct 1, 1983·European Journal of Cancer & Clinical Oncology·A PaccagnellaM V Fiorentino
Jan 31, 1987·Lancet·D E JoshuaH Kronenberg
Dec 31, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A RiccardiE Ascari
Dec 1, 1994·British Journal of Haematology·J A Child
Mar 1, 1984·European Journal of Cancer & Clinical Oncology·O A van DobbenburghH O Nieweg
Mar 1, 1994·Baillière's Clinical Haematology·F MandelliG Avvisati
Jan 1, 1983·Critical Reviews in Clinical Laboratory Sciences·D H Russell
Jan 1, 1991·Leukemia & Lymphoma·A SchattnerA Berrebi
Apr 28, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian G M DurieJohn Crowley
Nov 1, 1988·Cell and Tissue Kinetics·G UcciR Luoni
Jul 1, 1984·British Journal of Haematology·B G Durie
Jan 1, 1982·Metabolic Bone Disease & Related Research·R Bataille, J Sany
Jan 1, 1982·European Journal of Cancer & Clinical Oncology·R BatailleJ Sany
Jan 15, 1987·Cancer·R BatailleJ Sany
Jan 1, 1989·Journal of Clinical Laboratory Analysis·M J HicksD J Slymen
Jun 1, 1989·Australian and New Zealand Journal of Medicine·R D BrownH Kronenberg
Sep 6, 2012·Nature Reviews. Clinical Oncology·Alessandro GozzettiMonica Bocchia
Oct 16, 2016·Blood·S Vincent Rajkumar, Jean Luc Harousseau
May 15, 2004·British Journal of Haematology·Mohamad A HusseinRalph Ellison
Oct 1, 1984·Hematological Oncology·J A Child, M R Kushwaha
May 1, 1989·Postgraduate Medical Journal·R A Coward
Jan 1, 1982·Clinical and Laboratory Haematology·R M Rowan
Nov 1, 1987·European Journal of Haematology·D A Galton, F Brito-Babapulle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.